Replimune Group
REPL
77 hedge funds and large institutions have $631M invested in Replimune Group in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 4 closing their positions.
525% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 4
180% more capital invested
Capital invested by funds: $225M → $631M (+$406M)
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
38% more funds holding
Funds holding: 56 → 77 (+21)
7.4% more ownership
Funds ownership: 61.72% → 69.12% (+7.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$8.58M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$8.41M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.85M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$6.01M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$12M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$3.37M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.87M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$693K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$596K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | +$1.01K | +57 | New |
|
|
MWNA
77
Marshall Wace North America
New York
| – | -$3.37M | -338,179 | Closed |
|
78
Millennium Management
New York
| – | -$594K | -59,602 | Closed |
|
|
CS
79
Credit Suisse
Zurich,
Switzerland
| – | -$487K | -48,924 | Closed |
|
|
AG
80
Algert Global
San Francisco,
California
| – | -$118K | -11,810 | Closed |
|
|
BCA
81
Berman Capital Advisors
Atlanta,
Georgia
| – | +$566 | +32 | New |
|
REPL Hedge Fund Activity: Q2 2020 in Review
77 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2020, worth a combined $631M — up 180% from $225M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new REPL positions and 4 closed out — a net gain of 21 holders — while 36 added to existing stakes and 13 trimmed.
The largest buyer was Corriente Advisors, opening a new position worth an estimated $8.58M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $12M.
- 77 institutional investors held Replimune Group (REPL) as of Q2 2020, up from 56 in Q1 2020.
- Funds reported $631M of Replimune Group stock for Q2 2020, up 180% quarter-over-quarter.
- 25 funds opened new Replimune Group positions in Q2 2020 and 4 closed out, a net change of +21 holders.
- The largest Replimune Group buyer in Q2 2020 was Corriente Advisors, an estimated $8.58M added.
- The largest Replimune Group seller in Q2 2020 was Bain Capital Life Sciences Investors, an estimated $12M sold.
Based on aggregated 13F filings for Q2 2020.